A prospective observational cohort study evaluating short-term hyperbaric oxygen therapy has demonstrated significant, time-dependent increases in relative telomere length alongside reductions in specific senescence-associated T-cell phenotypes in human peripheral blood mononuclear cells. Conducted in an adult cohort comprising both apparently healthy individuals and patients receiving hyperbaric treatment for clinical indications, the intervention consisted of thirty standardized sessions delivering high-pressure oxygen. Repeated measurements analyzed through linear mixed-effects modeling showed that relative telomere length increased by up to twenty-nine percent after the full protocol, while the circulating proportions of late-differentiated cytotoxic T cells declined. Circulating pro-inflammatory and anti-inflammatory cytokine concentrations did not exhibit uniform longitudinal changes across the entire participant population, but demographic and metabolic factors such as age, biological sex, and body mass index significantly influenced the timing and magnitude of immune biomarker changes.
Biological aging across human physiological systems is characterized by progressive functional deterioration, with the immune system experiencing early and clinically meaningful alterations collectively designated as immunosenescence. This progressive dysfunction compromises host immune surveillance, reduces responsiveness to vaccination, and correlates with elevated susceptibility to age-related pathological conditions. At cellular and molecular scales, the immunosenescence cascade is driven by interconnected mechanisms that include progressive telomere attrition, the selective accumulation of late-differentiated or exhausted immune cell phenotypes, and persistent, low-grade systemic inflammation often termed inflammaging. Within peripheral blood mononuclear cells, telomere length reflects cumulative replicative cycles and chronic antigenic stimulation. Concurrently, senescent T cells frequently lose critical co-stimulatory surface receptors, specifically CD28 and CD27, especially within the CD8-positive compartment. These senescent cells exhibit diminished proliferative reserve, altered effector properties, and contribute to circulating inflammatory mediators through a senescence-associated secretory phenotype.
To investigate whether these established aging-related immune parameters can be systematically modulated through an environmental and atmospheric intervention, researchers enrolled one hundred adult participants aged between twenty and seventy-nine years at the First Hospital of China Medical University between 2021 and 2023. The observational cohort captured real-world heterogeneity by incorporating both healthy individuals undergoing hyperbaric exposure for health management and clinical patients treated for documented medical indications. Eligibility required the physical ability to complete hyperbaric procedures safely and consent to longitudinal venous sampling. Individuals with recent hyperbaric therapy within three months or established medical contraindications, including pneumothorax, pulmonary bullae, eustachian tube obstruction, or severe claustrophobia, were excluded from participation. The study protocol received institutional ethics review approval, conformed to the Declaration of Helsinki, and was formally recorded in the Chinese Clinical Trial Registry under identifier ChiCTR2500110103.
The therapeutic protocol was administered inside a specialized multiplace hyperbaric chamber with strict operational oversight from qualified hyperbaric medical personnel. Each individual session comprised a twenty-minute initial pressurization phase reaching 2.5 atmospheres absolute, followed by sixty minutes of continuous hundred percent oxygen respiration delivered through a specialized face mask, punctuated by ten-minute ambient air breaks every half hour to mitigate potential central nervous system toxicity. The session concluded with a thirty-minute controlled decompression phase. The entire treatment program encompassed thirty discrete sessions structured with an obligatory two-day rest interval after every ten completed treatments. Clinical staff monitored participants continuously for potential adverse events, including signs of central oxygen toxicity such as twitching or seizures, barotrauma affecting the auditory or paranasal cavities, and overall hemodynamic tolerance. Participants maintained their habitual lifestyles without concurrent experimental pharmacological or behavioral interventions.
Biological samples were systematically collected across four standardized observation checkpoints: at pre-treatment baseline, and immediately following the completion of ten, twenty, and thirty hyperbaric sessions. At each sampling interval, approximately five milliliters of venous whole blood was collected into anticoagulated tubes containing ethylenediaminetetraacetic acid and transferred on ice to the laboratory within thirty minutes. Peripheral blood mononuclear cells were isolated through density-gradient centrifugation over Ficoll-Paque Plus medium at four hundred times gravity for thirty minutes at twenty degrees Celsius. The resulting mononuclear cell layer was carefully harvested, washed twice in phosphate-buffered saline, and resuspended in staining buffer. Cell aliquots containing approximately one million cells were utilized for downstream analytical assays, with samples exhibiting inadequate cell yields or suboptimal flow cytometric quality excluded from final immunophenotyping determinations.
Relative telomere length was determined from genomic DNA extracted from isolated mononuclear cells using real-time quantitative polymerase chain reaction with SYBR Green master mix, normalizing telomere repeat amplification against the human single-copy reference gene 36B4 using the comparative threshold cycle formula with baseline values serving as the internal reference calibrator. Valid longitudinal telomere measurements were successfully obtained for ninety-seven participants. Flow cytometric immunophenotyping was simultaneously executed on ninety-three participants to quantify senescence-associated T-cell subsets based on surface expression of CD28 and CD27. Cells were stained with specific fluorochrome-conjugated monoclonal antibodies targeting CD3, CD4, CD8, CD28, and CD27, evaluating CD28 and CD27 in separate parallel tubes because both antibodies utilized phycoerythrin conjugation. Singlet lymphocytes were gated by scatter properties to calculate percentages of negative subsets relative to parental CD4-positive or CD8-positive T-cell compartments.
Circulating inflammatory cytokine concentrations were determined in duplicate from plasma aliquots using a multiplex bead-based cytometric bead array platform analyzed on a flow cytometer. The multiplex panel quantified the pro-inflammatory cytokines tumor necrosis factor-alpha and interleukin-1beta alongside the immunoregulatory cytokine interleukin-10, utilizing standard calibration curves with intra-assay coefficients of variation maintained strictly below ten percent. To control for analytical drift across the longitudinal timeframe, samples from identical participants were processed in unified assay batches. Statistical evaluations were performed using linear mixed-effects models that accommodated within-subject correlation across repeated measurements and unbalanced data structures. Models treated treatment session time points as categorical fixed effects while incorporating participant-specific random intercepts, adjusting for baseline biomarker values, chronological age, sex, and body mass index, and testing explicit interaction terms.
Linear mixed-effects modeling adjusted for baseline measurements revealed a highly significant, progressive increase in relative telomere length across the thirty-session intervention. Normalized relative telomere length rose from 1.000 at baseline to an average of 1.138 after ten sessions, 1.202 after twenty sessions, and 1.299 after thirty sessions. In statistical models, this represented an estimated increase of 13.9 percent at session ten, 20.3 percent at session twenty, and 29.0 percent at session thirty, with the final increment yielding a substantial effect size marked by a Cohen’s d of 0.70. This temporal trajectory remained statistically robust after comprehensive multivariate adjustment for chronological age, biological sex, and body mass index. Crucially, interaction terms between session numbers and demographic variables were non-significant, demonstrating that the upward trajectory of peripheral blood mononuclear cell telomere length occurred consistently across diverse participant subgroups.
In contrast to the uniform expansion of telomeric measurements, phenotypic remodeling within circulating T cells displayed selective compartmentalization, with CD8-positive cytotoxic lymphocytes demonstrating pronounced longitudinal shifts while helper CD4-positive compartments exhibited minimal alterations. The mean proportion of CD28-negative CD8-positive T cells decreased from 48.61 percent at baseline to 45.63 percent at ten sessions and 47.09 percent at thirty sessions, showing a statistically significant overall time effect in baseline-adjusted mixed models. Pairwise contrasts identified significant percentage-point reductions at ten sessions and thirty sessions. Similarly, the proportion of CD27-negative CD8-positive T cells declined from 42.27 percent at baseline to 39.84 percent at ten sessions and 39.24 percent at twenty sessions, demonstrating a significant overall fixed effect. Conversely, CD27-negative CD4-positive T cells showed only modest reductions that did not achieve statistical significance across the full model, while CD28-negative CD4-positive proportions remained essentially stable throughout the thirty-session protocol.
Subgroup interaction analyses highlighted marked inter-individual heterogeneity in T-cell phenotypic responses, showing that younger chronological age, female sex, and normal body mass index were associated with earlier and more pronounced cellular remodeling. Young adults aged twenty to thirty-nine years exhibited progressive, significant reductions in CD28-negative CD8-positive cells that reached an estimated decline of 11.025 percentage points after thirty sessions, whereas elderly participants aged sixty to seventy-nine showed no statistically significant reductions. Sex-stratified models demonstrated persistent reductions in CD28-negative CD8-positive proportions among female participants across all post-baseline intervals, whereas male participants exhibited no significant change. Similarly, participants with normal weight under regional Chinese criteria showed consistent reductions in CD28-negative CD8-positive subsets, whereas overweight individuals exhibited no measurable shifts, suggesting that underlying metabolic stress and adiposity may dampen cellular plasticity during hyperbaric interventions.
Circulating plasma cytokines exhibited dynamic, transient shifts rather than uniform directional trajectories across the thirty-session intervention, with overall fixed effects of time failing to reach significance across the unstratified cohort. However, significant interaction terms revealed pronounced early decreases restricted to specific demographic subgroups after ten hyperbaric sessions. Plasma tumor necrosis factor-alpha and interleukin-1beta concentrations declined significantly after ten sessions among male participants and middle-aged adults aged forty to fifty-nine years, while female participants and older individuals displayed no comparable early decrease. Parallel reductions in plasma interleukin-10 were also observed in males and middle-aged individuals at the ten-session mark. The concurrent drop in this anti-inflammatory mediator indicates a coordinated recalibration of cytokine networks away from heightened basal immune activation and compensatory regulation, rather than simple immune suppression.
The study authors noted multiple physiological mechanisms that could potentially explain the observed findings, while emphasizing essential methodological constraints that temper definitive clinical conclusions. The progressive rise in bulk mononuclear telomere length might reflect intrinsic genomic preservation activated via intermittent hyperoxia and hypoxia-responsive signaling networks, or alternatively, an indirect compositional shift caused by the selective clearance or mobilization of short-telomere senescent subsets. Most importantly, the investigation lacked a parallel non-treatment or sham-controlled comparator arm, precluding definitive causal attribution and leaving room for unmeasured confounding from routine clinical care or natural regression. Furthermore, immunophenotyping was restricted to surface receptor markers without accompanying functional proliferation or cytotoxicity assays, and the exploratory subgroup analyses require confirmation in larger, randomized clinical trials designed to assess long-term durability.
Subject of Research: Modulation of immune aging biomarkers during short-term hyperbaric oxygen therapy
Article Title: Hyperbaric oxygen therapy modulates immune aging in a personalized manner: a linear mixed-effects analysis
Article References: Chu, H.-T., Zhao, H., Wang, S.-S., Meng, X., Wang, D., Zhu, X.-B., Wang, Y., & Yang, X.-W. (2026). Hyperbaric oxygen therapy modulates immune aging in a personalized manner: a linear mixed-effects analysis. Immunity & Ageing, 23(1), Article 43. https://doi.org/10.1186/s12979-026-00587-3
Image Credits: AI Generated
DOI: 10.1186/s12979-026-00587-3
Keywords: hyperbaric oxygen therapy, immunosenescence, telomere length, T-cell senescence, CD28, CD27, cytokines, tumor necrosis factor-alpha, interleukin-10, interleukin-1beta, peripheral blood mononuclear cells, biological aging, linear mixed-effects models, flow cytometry, RT-qPCR, body mass index
News Source: Beatrice Stafford. (November 18, 2026). Hyperbaric Oxygen Therapy Modulates Human Immune Aging Markers in a Cohort Study. Scienmag.



